Cargando…
Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine
Immune thrombocytopenic purpura (ITP) is a rare hematologic condition through to affect 3.3 in 100,000 adults per year in the United States. Many cases of immune thrombocytopenia are diagnosed incidentally with laboratory tests that reveal low platelet count, without a clear cause. However, when pla...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
UMF “Gr. T. Popa” Iasi Publishing House
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565691/ https://www.ncbi.nlm.nih.gov/pubmed/34754937 http://dx.doi.org/10.22551/2021.31.0802.10182 |